Literature DB >> 9504534

Leptin.

J Auwerx1, B Staels.   

Abstract

Leptin (from the Greek leptos=thin) was identified only 3 years ago. It has attracted huge attention both scientifically, with more than 600 publications, and in the media, where this protein has been portrayed as the way to a cure for obesity. Indeed, leptin was first described as an adipocyte-derived signalling factor, which, after interaction with its receptors, induced a complex response including control of bodyweight and energy expenditure. Leptin seems in addition to its role in metabolic control to have important roles in reproduction and neuroendocrine signalling. Human obesity is a complex disorder, with many factors playing a part; the pathophysiology of leptin is not as simple as it seems to be in rodent models of obesity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9504534     DOI: 10.1016/S0140-6736(97)06348-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  71 in total

1.  A potential role for adjunctive vitamin D therapy in the management of weight gain and metabolic side effects of second-generation antipsychotics.

Authors:  Benjamin U Nwosu; Bruce Meltzer; Louise Maranda; Carol Ciccarelli; Daniel Reynolds; Laura Curtis; Jean King; Jean A Frazier; Mary M Lee
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

Review 2.  Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition.

Authors:  Jingjing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-12-14       Impact factor: 2.370

3.  Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia.

Authors:  France Gagnon; Gail P Jarvik; Michael D Badzioch; Arno G Motulsky; John D Brunzell; Ellen M Wijsman
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

4.  Genes involved in obesity: Adipocytes, brain and microflora.

Authors:  L Macia; O Viltart; C Verwaerde; M Delacre; A Delanoye; C Grangette; I Wolowczuk
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

5.  A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.

Authors:  Yoshihiro Shiomi; Toshimasa Yamauchi; Masato Iwabu; Miki Okada-Iwabu; Ryo Nakayama; Yuki Orikawa; Yoshichika Yoshioka; Koichiro Tanaka; Kohjiro Ueki; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

6.  Leptin and the post-operative inflammatory response. More insights into the correlation with the clinical course and glucocorticoid administration.

Authors:  D Modan-Moses; H Kanety; O Dagan; S Ehrlich; D Lotan; C Pariente; I Novikov; G Paret
Journal:  J Endocrinol Invest       Date:  2010-04-12       Impact factor: 4.256

7.  Psychological state, quality of life, and body composition in postmenopausal women with osteoporosis in Lithuania.

Authors:  Lina Lasaite; Aurelija Krasauskiene
Journal:  Arch Osteoporos       Date:  2009-12-01       Impact factor: 2.617

8.  Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: Role of obesity.

Authors:  Ahmet Ursavas; Yesim Ozarda Ilcol; Nazan Nalci; Mehmet Karadag; Ercument Ege
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

9.  Circulating levels of leptin, adiposity and breast cancer risk.

Authors:  M-H Wu; Y-C Chou; W-Y Chou; G-C Hsu; C-H Chu; C-P Yu; J-C Yu; C-A Sun
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

10.  Short Hypoxia Does not Affect Plasma Leptin in Healthy Men under Euglycemic Clamp Conditions.

Authors:  Andre Schmoller; Michaela Voss; Hartmut Gehring; Sebastian Rudolf; Ulrich Schweiger; Bernd Schultes; Kerstin M Oltmanns
Journal:  Int J Endocrinol       Date:  2009-06-01       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.